Consolidated Statements of Cash Flows - USD ($) |
12 Months Ended | ||||||||
---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2025 |
Mar. 31, 2024 |
Mar. 31, 2023 |
|||||||
CASH FLOWS FROM OPERATING ACTIVITIES | |||||||||
Loss before taxation | $ (5,212,879) | $ (4,862,470) | $ (9,257,598) | ||||||
Adjustments for: | |||||||||
Amortization - right-of-use assets | 125,575 | 99,580 | |||||||
Depreciation - property, plant and equipment | 3,696 | 1,007 | |||||||
Impairment losses (reversed) recognized in respect of trade receivables | (2,844) | (400) | 5,025 | ||||||
Bad debt written off | 12,064 | 21,522 | 14,752 | ||||||
Write-off of due from related company | [1] | 81,347 | |||||||
Finance costs | 410,167 | 552,651 | 220,460 | ||||||
Share option awards | 859,685 | 1,352,835 | 587,821 | ||||||
Share-based payments expenses on anti-dilution issuance of preferred shares | [2],[3] | 369,648 | |||||||
IPO expenses charged to P&L | 1,659,081 | ||||||||
Net fair value loss of convertible loan notes | 639,000 | 374,000 | 19,000 | ||||||
Net fair value (loss) gain of preferred shares | (4,117,648) | (4,101,000) | 1,841,000 | ||||||
Operating cash flows before movements in working capital | (5,258,151) | (6,478,239) | (6,568,533) | ||||||
Trade receivables | (1,221,431) | 86,332 | (43,719) | ||||||
Other receivables, deposit and prepayment | (955,348) | (210,936) | 132,684 | ||||||
Contract assets | 68,604 | (42,365) | 42,158 | ||||||
Due from a related company | (39,815) | (41,532) | |||||||
Trade and other payables | (478,610) | 841,155 | (131,331) | ||||||
Deferred revenue | 182,598 | (12,840) | 18,955 | ||||||
Cash generated from operations | (7,662,338) | (5,856,708) | (6,591,318) | ||||||
Income tax paid | (8,917) | ||||||||
Net cash used in operating activities | (7,671,255) | (5,856,708) | (6,591,318) | ||||||
CASH FLOWS FROM INVESTING ACTIVITIES | |||||||||
Payment to rental deposit | (10,032) | ||||||||
Cash used in investing activities | (10,032) | ||||||||
CASH FLOWS FROM FINANCING ACTIVITIES | |||||||||
Issue of shares under global offerings | 10,608,750 | ||||||||
Payment of transaction costs of issue of new shares | (2,948,791) | ||||||||
Loans from immediate holding company | 3,410,461 | 564,483 | 2,250,000 | ||||||
Advances from immediate holding company | 713,719 | 5,345,423 | 600,000 | ||||||
Proceeds from shares issued | 50 | ||||||||
Proceeds from issuance of convertible loan notes | 100,000 | 3,250,000 | |||||||
Loan from a related company | 1,000,000 | ||||||||
Repayment of due to immediate holding company | (600,000) | ||||||||
Repayment of lease liabilities | (138,962) | (109,754) | |||||||
Placement of restricted bank balance | (399,400) | ||||||||
Repayment of loan from immediate holding company | (530,019) | (1,150,000) | |||||||
Net cash generated from financing activities | 10,715,808 | 4,750,152 | 6,500,000 | ||||||
NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS | 3,034,521 | (1,106,556) | (91,318) | ||||||
Cash and cash equivalents at the beginning of the year | 76,620 | 1,183,176 | 1,274,494 | ||||||
CASH AND CASH EQUIVALENTS AT THE END OF THE YEAR | $ 3,111,141 | $ 76,620 | $ 1,183,176 | ||||||
|